Cargando…

Otitis Media Practice During the COVID-19 Pandemic

The global coronavirus disease-2019 (COVID-19) pandemic has changed the prevalence and management of many pediatric infectious diseases, including acute otitis media (AOM). Coronaviruses are a group of RNA viruses that cause respiratory tract infections in humans. Before the COVID-19 pandemic, coron...

Descripción completa

Detalles Bibliográficos
Autores principales: Marom, Tal, Pitaro, Jacob, Shah, Udayan K., Torretta, Sara, Marchisio, Paola, Kumar, Ayan T., Barth, Patrick C., Tamir, Sharon Ovnat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777025/
https://www.ncbi.nlm.nih.gov/pubmed/35071032
http://dx.doi.org/10.3389/fcimb.2021.749911
_version_ 1784636968227831808
author Marom, Tal
Pitaro, Jacob
Shah, Udayan K.
Torretta, Sara
Marchisio, Paola
Kumar, Ayan T.
Barth, Patrick C.
Tamir, Sharon Ovnat
author_facet Marom, Tal
Pitaro, Jacob
Shah, Udayan K.
Torretta, Sara
Marchisio, Paola
Kumar, Ayan T.
Barth, Patrick C.
Tamir, Sharon Ovnat
author_sort Marom, Tal
collection PubMed
description The global coronavirus disease-2019 (COVID-19) pandemic has changed the prevalence and management of many pediatric infectious diseases, including acute otitis media (AOM). Coronaviruses are a group of RNA viruses that cause respiratory tract infections in humans. Before the COVID-19 pandemic, coronavirus serotypes OC43, 229E, HKU1, and NL63 were infrequently detected in middle ear fluid (MEF) specimens and nasopharyngeal aspirates in children with AOM during the 1990s and 2000s and were associated with a mild course of the disease. At times when CoV was detected in OM cases, the overall viral load was relatively low. The new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative pathogen responsible for the eruption of the COVID-19 global pandemic. Following the pandemic declaration in many countries and by the World Health Organization in March 2020, preventive proactive measures were imposed to limit COVID-19. These included social distancing; lockdowns; closure of workplaces; kindergartens and schools; increased hygiene; use of antiseptics and alcohol-based gels; frequent temperature measurements and wearing masks. These measures were not the only ones taken, as hospitals and clinics tried to minimize treating non-urgent medical referrals such as OM, and elective surgical procedures were canceled, such as ventilating tube insertion (VTI). These changes and regulations altered the way OM is practiced during the COVID-19 pandemic. Advents in technology allowed a vast use of telemedicine technologies for OM, however, the accuracy of AOM diagnosis in those encounters was in doubt, and antibiotic prescription rates were still reported to be high. There was an overall decrease in AOM episodes and admissions rates and with high spontaneous resolution rates of MEF in children, and a reduction in VTI surgeries. Despite an initial fear regarding viral shedding during myringotomy, the procedure was shown to be safe. Special draping techniques for otologic surgery were suggested. Other aspects of OM practice included the presentation of adult patients with AOM who tested positive for SARS-2-CoV and its detection in MEF samples in living patients and in the mucosa of the middle ear and mastoid in post-mortem specimens.
format Online
Article
Text
id pubmed-8777025
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87770252022-01-22 Otitis Media Practice During the COVID-19 Pandemic Marom, Tal Pitaro, Jacob Shah, Udayan K. Torretta, Sara Marchisio, Paola Kumar, Ayan T. Barth, Patrick C. Tamir, Sharon Ovnat Front Cell Infect Microbiol Cellular and Infection Microbiology The global coronavirus disease-2019 (COVID-19) pandemic has changed the prevalence and management of many pediatric infectious diseases, including acute otitis media (AOM). Coronaviruses are a group of RNA viruses that cause respiratory tract infections in humans. Before the COVID-19 pandemic, coronavirus serotypes OC43, 229E, HKU1, and NL63 were infrequently detected in middle ear fluid (MEF) specimens and nasopharyngeal aspirates in children with AOM during the 1990s and 2000s and were associated with a mild course of the disease. At times when CoV was detected in OM cases, the overall viral load was relatively low. The new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative pathogen responsible for the eruption of the COVID-19 global pandemic. Following the pandemic declaration in many countries and by the World Health Organization in March 2020, preventive proactive measures were imposed to limit COVID-19. These included social distancing; lockdowns; closure of workplaces; kindergartens and schools; increased hygiene; use of antiseptics and alcohol-based gels; frequent temperature measurements and wearing masks. These measures were not the only ones taken, as hospitals and clinics tried to minimize treating non-urgent medical referrals such as OM, and elective surgical procedures were canceled, such as ventilating tube insertion (VTI). These changes and regulations altered the way OM is practiced during the COVID-19 pandemic. Advents in technology allowed a vast use of telemedicine technologies for OM, however, the accuracy of AOM diagnosis in those encounters was in doubt, and antibiotic prescription rates were still reported to be high. There was an overall decrease in AOM episodes and admissions rates and with high spontaneous resolution rates of MEF in children, and a reduction in VTI surgeries. Despite an initial fear regarding viral shedding during myringotomy, the procedure was shown to be safe. Special draping techniques for otologic surgery were suggested. Other aspects of OM practice included the presentation of adult patients with AOM who tested positive for SARS-2-CoV and its detection in MEF samples in living patients and in the mucosa of the middle ear and mastoid in post-mortem specimens. Frontiers Media S.A. 2022-01-07 /pmc/articles/PMC8777025/ /pubmed/35071032 http://dx.doi.org/10.3389/fcimb.2021.749911 Text en Copyright © 2022 Marom, Pitaro, Shah, Torretta, Marchisio, Kumar, Barth and Tamir https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Marom, Tal
Pitaro, Jacob
Shah, Udayan K.
Torretta, Sara
Marchisio, Paola
Kumar, Ayan T.
Barth, Patrick C.
Tamir, Sharon Ovnat
Otitis Media Practice During the COVID-19 Pandemic
title Otitis Media Practice During the COVID-19 Pandemic
title_full Otitis Media Practice During the COVID-19 Pandemic
title_fullStr Otitis Media Practice During the COVID-19 Pandemic
title_full_unstemmed Otitis Media Practice During the COVID-19 Pandemic
title_short Otitis Media Practice During the COVID-19 Pandemic
title_sort otitis media practice during the covid-19 pandemic
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777025/
https://www.ncbi.nlm.nih.gov/pubmed/35071032
http://dx.doi.org/10.3389/fcimb.2021.749911
work_keys_str_mv AT maromtal otitismediapracticeduringthecovid19pandemic
AT pitarojacob otitismediapracticeduringthecovid19pandemic
AT shahudayank otitismediapracticeduringthecovid19pandemic
AT torrettasara otitismediapracticeduringthecovid19pandemic
AT marchisiopaola otitismediapracticeduringthecovid19pandemic
AT kumarayant otitismediapracticeduringthecovid19pandemic
AT barthpatrickc otitismediapracticeduringthecovid19pandemic
AT tamirsharonovnat otitismediapracticeduringthecovid19pandemic